The Food and Drug Administration is investigating several hospitalizations and deaths potentially linked to counterfeit semaglutide drugs, such as Ozempic, according to multiple reports. At least three Americans have been hospitalized after injecting themselves with suspected counterfeit products, CBS News reported. The hospitalizations under investigation are believed to be among 42 cases reported to the …
At least three Americans were reportedly hospitalized after using suspected counterfeit semaglutide medications, including Novo Nordisk’s diabetes drug Ozempic, according to records released by the Food and Drug Administration. Ozempic and Wegovy, another semaglutide drug from Novo Nordisk, have been in shortage for months amid booming sales for their use in weight loss. These hospitalizations …
Much has changed in the reporting of radiology results since the 21st Century Cures Act was signed into law on December 13, 2016. The Cures Act was designed to help accelerate new innovations and progress in the delivery of patient care, significantly undercutting its “information blocking” prohibitions. Even without enforcement mechanisms in place, information blocking …
Last month, the Consumer Financial Protection Bureau (CFPB) began a rulemaking process that, if enacted, would reshape the credit reporting and debt collection landscape and could have a detrimental effect on financial results of medical and dental providers. As we noted previously, the CFPB, led by Rohit Chopra, continues to make medical financing and debt …